West Michigan Advisors’s Charles River Laboratories CRL Stock Holding History

West Michigan Advisors’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,088	Closed	-$201K	–	221
2024 Q4	$201K	Sell	1,088 -72	-6%	-$13.9K	0.06%	221
2024 Q3	$228K	Sell	1,160 -14	-1%	-$2.91K	0.07%	172
2024 Q2	$243K	Buy	1,174 +2	+0.2%	+$453	0.08%	160
2024 Q1	$318K	Sell	1,172 -30	-2%	-$7.16K	0.1%	127
2023 Q4	$284K	Buy	1,202 +105	+10%	+$20.6K	0.11%	119
2023 Q3	$215K	Sell	1,097 -13	-1%	-$2.67K	0.11%	134
2023 Q2	$233K	Hold	1,110	–	–	0.09%	185
2023 Q1	$224K	Buy	1,110 +20	+2%	+$4.53K	0.13%	129
2022 Q4	$238K	Hold	1,090	–	–	0.17%	96
2022 Q3	$215K	Buy	+1,090	New	+$235K	0.19%	94
2022 Q2	–	Sell	-777	Closed	-$221K	–	120
2022 Q1	$221K	Buy	777 +12	+2%	+$3.7K	0.15%	116
2021 Q4	$288K	Buy	+765	New	+$297K	0.21%	93

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

West Michigan Advisors's CRL Position: Q1 2025 in Review

West Michigan Advisors sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 1,088 shares — an estimated $201K sold.

West Michigan Advisors first reported a position in CRL in Q4 2021 and held it in 12 quarters. The position peaked at $318K in Q1 2024. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

West Michigan Advisors reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
West Michigan Advisors sold 1,088 Charles River Laboratories shares in Q1 2025, an estimated $201K.
West Michigan Advisors first reported a position in Charles River Laboratories in Q4 2021 and held it in 12 quarters.
West Michigan Advisors's Charles River Laboratories position peaked at $318K in Q1 2024.
561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on West Michigan Advisors's 13F filing for Q1 2025, filed 9 May 2025.